Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma

[1]  D. Ihde.  Small Cell Lung Cancer: State-of-the-Art Therapy 1994 , 1995 .

[2]  H. Hansen,et al.  Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Troell,et al.  Detection of metastases from head and neck cancers , 1995, The Laryngoscope.

[4]  M. Pandian,et al.  Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer. , 1993, British Journal of Cancer.

[5]  J P Pignon,et al.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.

[6]  D. Ihde,et al.  Chemotherapy of Lung Cancer , 1992 .

[7]  D. Payne,et al.  The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Crowley,et al.  Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  S. Steinberg,et al.  Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Yarnold,et al.  Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Crowley,et al.  Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Spiegelman,et al.  Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Abrams,et al.  Staging, prognostic factors, and special considerations in small cell lung cancer. , 1988, Seminars in oncology.

[14]  D. Ihde,et al.  Therapy of small cell lung cancer: a perspective on two decades of clinical research. , 1988, Seminars in oncology.

[15]  P. Bunn,et al.  Innovative and future approaches to small cell lung cancer treatment. , 1988, Seminars in oncology.

[16]  G. Deboer,et al.  Prognostic factors for small cell carcinoma of the lung. , 1988, European journal of cancer & clinical oncology.

[17]  P. Vezzoni,et al.  Lactate Dehydrogenase Levels in Cellular Extracts of Human Malignant Lymphomas , 1983, Tumori.

[18]  R. Spooner,et al.  Serum enzymes in colorectal cancer , 1979, Cancer.

[19]  W. Mcleish,et al.  Carcinocythemia due to metastatic oat-cell carcinoma of the lung. , 1979, Canadian Medical Association journal.

[20]  Minoru Matsuda,et al.  Small cell carcinoma of the lung: clinical and cytomorphological studies in relation to its response to chemotherapy. , 1977, Gan.